Last reviewed · How we verify
NCT04127474
Expression of Trefoil Factors and Adrenomedullin in Subjects With Chronic Periodontitis and Coronary Heart Disease
trial in Coronary Heart Disease in 75 participants. Status unknown.
20 December 2020
Quick facts
| Lead sponsor | Meenakshi Ammal Dental College and Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 14 October 2019 |
| Primary completion | 20 December 2020 |
| Estimated completion | 20 November 2021 |
| Sites | 1 location across India |
Conditions studied
- Coronary Heart Disease — all drugs for Coronary Heart Disease →
- Periodontal Diseases — all drugs for Periodontal Diseases →
Sponsor
Meenakshi Ammal Dental College and Hospital
Who can join
Adults 30 to 65, any sex, with Coronary Heart Disease or Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the demographic variables, periodontal parameters and to determine the expression of Trefoil factors 2 and 3 and Adrenomedullin in unstimulated saliva samples of periodontally healthy subjects with coronary heart disease and generalised chronic periodontitis subjects with and without coronary heart disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04127474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Heart Disease
Currently open trials in the same condition.
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07110415 — Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by · Phase 4 · recruiting
- NCT07451873 — Glycocalyx and Oxidative Stress in Endothelial Function (Part 2) · recruiting
- NCT07118930 — Study of Sivelestat Sodium in OPCABG · Phase 2 · recruiting
Other Meenakshi Ammal Dental College and Hospital trials
Trials by the same sponsor.
- NCT07504744 — Klotho Gene, Red Complex Bacteria and Periodontal Viruses in Patients With and Without Periodontitis and Acute Coronary · not yet recruiting
- NCT07353606 — Cofilin-2 (rs80358250) and Lactoferrin (rs1126478) Polymorphism and Protein Levels With Non Surgical Periodontal Therapy · NA · active not recruiting
- NCT05828368 — DKK-3 rs11544814 and CFH rs10737680 Polymorphism and Protein Levels With Non Surgical Periodontal Therapy in Periodontit · NA · unknown
- NCT05663476 — NSPT On Vitronectin And Fetuin-A Levels In Patients With Periodontitis And Coronary Artery Disease · NA · unknown
- NCT05618743 — NSPT on Calprotectin and Periostin Levels · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04127474 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meenakshi Ammal Dental College and Hospital
- Last refreshed: 2 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04127474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing